Delivery Order SPE2DB24D2003-SPE2DB25FXMA2
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,720.90 on July 28, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injections. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Mounjaro 10 mg/0.5 mL pen injectors with a ceiling value of $6,286.18 under a firm fixed-price contract type. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract carries no set-aside designation...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,700.12 on July 28, 2025, for the supply of Mounjaro 12.5 mg/0.5 ml pen injections. This firm fixed price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by July 29, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,088.36 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Mounjaro 10 mg/0.5 ml pen injectors with a completion date of August 19, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for federal medical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,904.63 on August 9, 2025, for the supply of Mounjaro 15 mg/0.5 mL pen injectors. This firm fixed-price delivery order, with an ultimate completion date of August 11, 2025, is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's competitive capability in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,082.99 to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 mL pen injectors on July 24, 2025. This firm fixed-price delivery order, which is a child contract under a larger indefinite delivery vehicle, represents a routine pharmaceutical procurement for military healthcare needs. The contract was competitively awarded without set-aside designation and specifies performance at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 10 mg/0.5 ml pen injections valued at $2,197.04 with a firm fixed price contract type. The award was made on August 1, 2025, with an ultimate completion date of August 4, 2025, and does not utilize a set-aside designation. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injections, with a ceiling value of $1,738.69 and an ultimate completion date of August 18, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 ml pen injections on August 8, 2025, with a ceiling value of $2,176.72 and an ultimate completion date of August 11, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order contract to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pen injectors valued at $7,605.13. This is a firm fixed-price delivery order with an ultimate completion date of July 28, 2025, and represents a non-set-aside competitive award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB25FXMA2Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Mounjaro 10 mg/0.5 ml pen injections with a ceiling value of $12,268.99 and a firm fixed price structure. The contract, which represents a non-set-aside competitive award, is scheduled for completion by August 25, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.9 million through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains extensive federal contracting relationships with the Defense Logistics Agency for the procurement of medications, vaccines, medical devices, and specialized healthcare commodities supporting military and veteran healthcare systems. The parent indefinite delivery contract encompasses a broad portfolio of pharmaceutical products across multiple therapeutic domains, including specialty medications and brand-name and generic drugs, enabling the company to fulfill critical medical supply needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.3k | 8/22/25 |